In most prior studies, the primary diagnosis of SSCOHT was based on morphology, which can mimic a large variety of other ovarian tumors, and testing for SMARCA4 or BRG1 was done only retrospectively in morphologically diagnosed cases (5–7). This evidence concerns the gene SMARCA4 and ovarian neoplasm.